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Abstract In this paper the effect of uterine artery
embolization (UAE) on sexual functioning and body image
is investigated in a randomized comparison to hysterec-
tomy for symptomatic uterine ﬁbroids. The EMbolization
versus hysterectoMY (EMMY) trial is a randomized con-
trolled study, conducted at 28 Dutch hospitals. Patients
were allocated hysterectomy (n = 89) or UAE (n = 88).
Two validated questionnaires (the Sexual Activity Ques-
tionnaire [SAQ] and the Body Image Scale [BIS]) were
completed by all patients at baseline, 6 weeks, and 6, 12,
18, and 24 months after treatment. Repeated measurements
on SAQ scores revealed no differences between the groups.
There was a trend toward improved sexual function in both
groups at 2 years, although this failed to reach statistical
signiﬁcance except for the dimensions discomfort and habit
in the UAE arm. Overall quality of sexual life deteriorated
in a minority of cases at all time points, with no signiﬁcant
differences between the groups (at 24 months: UAE,
29.3%, versus hysterectomy, 23.5%; p = 0.32). At 24
months the BIS score had improved in both groups com-
pared to baseline, but the change was only signiﬁcant in the
UAE group (p = 0.009). In conclusion, at 24 months no
differences in sexuality and body image were observed
between the UAE and the hysterectomy group. On average,
both after UAE and hysterectomy sexual functioning and
body image scores improved, but signiﬁcantly so only after
UAE.
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Introduction
When hysterectomy looms as a deﬁnite treatment for
ﬁbroid related menorrhagia, women and their sexual part-
ners often express their concern about negative effects of
the operation on their sexual wellbeing [1–4]. Furthermore,
the uterus is considered important for a woman’s self-
image and sexual image and some women fear that they
will be ‘‘less of a woman’’ to their sexual partners [2, 4, 5].
Therefore a hysterectomy may also interfere with the
woman’s body image. These concerns may cause some
women to choose alternative treatment options [5]. During
the last decade, uterine artery embolization (UAE) has
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DOI 10.1007/s00270-007-9121-7emerged as an alternative treatment for hysterectomy [6].
UAE has been investigated in several case series and three
randomized controlled trials [7–13], but the advantage of
UAE in terms of sexual wellbeing and body image in
comparison to hysterectomy remains unknown, since ran-
domized controlled trials on this subject are not available
as yet. Randomized controlled data are preferential to
nonrandomized data, since nonrandomized data tend to
overestimate treatment effect and are prone to selection
bias [14]. We initiated a randomized trial comparing UAE
and hysterectomy and have published several short-term
results previosly [15–17]. In the present paper, we compare
changes in sexuality and body image in patients with
symptomatic uterine ﬁbroids who were randomly assigned
to either UAE or hysterectomy.
Materials and Methods
Study Design
The details of our study design have been described else-
where and are discussed here brieﬂy [15]. The EMMY trial
(EMbolization versus hysterectoMY) is a prospective ran-
domized multicenter clinical trial with 28 participating
hospitals in the Netherlands. Eligible patients met the fol-
lowing inclusion criteria: they were clinically diagnosed
with uterine ﬁbroids (conﬁrmed by ultrasonography), had
menorrhagia as the major complaint, were premenopausal,
and had no wish to conceive. All patients were candidates
for undergoing a hysterectomy: other treatment options
either had failed, were undesired, or had provided unsat-
isfactory results.
Eligible patients were informed verbally and in writing
about possible risks and beneﬁts of both procedures, and
were invited to participate in the trial. After written
informed consent had been obtained, patients were ran-
domly assigned (1:1) to UAE or hysterectomy by
computerized randomization, stratiﬁed for hospital. The
study was approved by the Dutch Central Committee
Involving Human Subjects (www.ccmo.nl) and the local
ethics committees of all participating hospitals.
Pre-assessment
All patients were assessed by the attending gynaecolo-
gist. Current symptoms and a complete medical and
gynaecological history were recorded. All patients
underwent a pelvic ultrasound to determine the number
of ﬁbroids and the size of the largest ﬁbroid. Sociode-
mographic characteristics were assessed by means of a
questionnaire.
Procedures
Uterine artery embolization
UAE was performed by an interventional radiologist. A
catheter was introduced into the femoral artery and
advanced over the aortic bifurcation to the contralateral
internal iliac artery, and digital subtraction angiography
was performed to identify the origin of the uterine artery.
When catheters were placed correctly, the UAE was carried
out. Polyvinyl alcohol (PVA) particles of 355–500 lm
were used in all procedures. UAE patients were advised to
refrain from sexual intercourse for at least 2 weeks and
thereafter, depending on their complaints.
Hysterectomy
The type of hysterectomy and the route of access were
determined by the gynecologist. The following procedures
were allowed: abdominal hysterectomy, vaginal hysterec-
tomy, laparoscopically assisted vaginal hysterectomy, and
laparoscopic hysterectomy. Both supravaginal and total
hysterectomies were allowed. After discharge hysterec-
tomy patients were advised not to have sex until the ﬁrst
outpatient visit at 6 weeks.
Questionnaires
Sexual functioning and body image were assessed by
means of patient questionnaires. At baseline, question-
naires were completed by all patients before
randomization. Follow-up questionnaires were completed
at 6 weeks and 6, 12, 18, and 24 months after treatment.
The questionnaire consisted of the Sexual Activity Ques-
tionnaire (SAQ), the Body Image Scale (BIS), and the
Mental Component Summary (MCS; as part of the Medical
Outcome Study Short Form [MOS SF-36]).
The SAQ, originally designed to investigate sexual
functioning in women treated with tamoxifen because of
a positive family history of breast cancer [18], is also
useful in women with nonmalignant gynecological dis-
orders [19]. In Table 1 the SAQ is displayed. The
questionnaire consists of three dimensions, and each
dimension yields its own score: pleasure from sexual
intercourse (desire, enjoyment, and satisfaction; score
range, 0–18), discomfort during intercourse (score range,
0–6), and habit (frequency; score range, 0–3). Pleasure
and habit are good with higher scores, while discomfort
is worse with higher scores. The SAQ was only ﬁlled
out by patients who were sexually active during the
month before receiving the questionnaire.
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their current sexual life in two questions: ‘‘How would you
describe the quality of your current sexual life?’’ and ‘‘How
well can you live with your current sexual life?’’ One of the
following responses could be ticked: ‘‘very good,’’ ‘‘good,’’
‘‘moderately good,’’ ‘‘neither good nor bad,’’ ‘‘moderately
bad,’’ ‘‘bad,’’ and ‘‘very bad.’’
The BIS was designed in order to asses changes in body
image among cancer patients [20]. The questionnaire was
also found reliable and valid in women with benign
gynecological conditions [21]. Table 1 displays the ques-
tions of which the BIS consists. Unfortunately, questions 2,
4, and 6 were not represented correctly in the questionnaire
due to a translation error. Therefore we decided to omit
these questions in order to attain a comparable outcome
between groups. The BIS score ranges from 0 to 30. A
higher BIS score indicates a worse body image.
In order to assess mental health before treatment as a
predictor of worse sexual function after treatment, the
MCS score of the 36-item MOS SF-36 was used [22]. This
was done because bad preoperative mental health is asso-
ciated with bad sexual life outcome [23].
Sample Size and Endpoints of the Present Study
The sample size was based on the primary endpoint of the
clinical study, published elsewhere [24]: the elimination of
menorrhagia in such way that hysterectomy could be
avoided in the UAE group in at least 75% of patients
within 2 years after the primary interventions.
The objective of the present study was to compare the
following endpoints between both interventions: the
number of sexually active patients, the scores yielded by
the SAQ and the BIS, the subjective quality of sexual life.
For this analysis, no separate power calculation was made.
Statistical Analysis
Data entry was performed using SPSS data entry for
Windows 3.0. A random sample of 10% of the question-
naires was visually double checked by an independent
second investigator, revealing a false entry level of 0.3%.
All false data entries were corrected.
All analyses were performed using SPSS (release
11.5.1) statistical software. Missing items in the ques-
tionnaire were treated as follows. For the SAQ no advice is
available on scoring missing items. If one item was miss-
ing, we regarded the dimension score (which the item was
part of) as being missing completely, according to earlier
research [25]. For the BIS no missing values were allowed
since three questions were omitted already. In these cases,
the entire score was omitted. For the three omitted ques-
tions, the individual mean score of the remaining seven
questions was imputed.
First,wedeterminedhowmanypatientsinbothtreatment
groups were sexually active before and after treatment. An
overall percentage per treatment group was calculated, after
whichsexualactivityinsubgroupswasassessed:thosebeing
sexually active and those not being sexually active before
treatment. Second, the mean of the dimension scores were
plotted for the hysterectomy and UAE group. Third, the
mean differences between all follow-up SAQ dimension
scores and baseline were compared between treatment
groups. This was only possible for patients who were sexu-
ally active both before and after treatment. Within group
changes were analyzed as well. Similar analyses were per-
formed for the BIS. Differences in pleasure, discomfort,
habit (SAQ), and body image (BIS) between groups over
Table 1 The Sexual Activity Questionnaire (SAQ) and the Body
Image Scale (BIS)
SAQ
Dimension pleasure
1. Was having sex an important part of your life in the last month?
2. Did you enjoy sexual activity in the last month?
3. Did you desire to have sex with your partner in the last month?
4. In general were you satisﬁed after sexual activity in the last
month?
5. How often did you engage in sexual activity in the last month?
6. Were you satisﬁed with the frequency of sex in the last month?
Dimension discomfort
1. Did you notice dryness of your vagina in the last month?
2. Did you feel pain or discomfort in the last month?
Dimension habit
1. How did the frequency of sexual behavior in the last month
compare with what is usual for you?
BIS
In the last month
1. Have you been feeling self-conscious about your appearance?
2. Have you felt less physically attractive as a result of your
menstrual bleeding problem?
3. Have you been dissatisﬁed with your appearance when dressed?
4. Have you been feeling less feminine as a result of your menstrual
bleeding problem?
5. Did you ﬁnd it difﬁcult to look at yourself naked?
6. Have you been feeling less sexually attractive as a result of your
menstrual bleeding problem?
7. Did you avoid people because of the way you felt about your
appearance?
8. Have you been feeling the treatment has left your body less
whole?
9. Have you felt dissatisﬁed with your body?
10. Have you been dissatisﬁed with the appearance of your scar?
Questions on the BIS shown in italics have been omitted
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123time were tested with repeated measurement analysis,
excludingthe6-weekmeasurementfortheSAQ,sinceahigh
proportionofpatients was expected not tobe sexually active
at that time and therefore not to yield a score. Differences in
continuous variables were tested with Student’s t test. Dif-
ferences in data with skewed distributions were tested with
the nonparametric Mann-Whitney U test.
The two added questions on the quality of current sexual
life were compared between the groups using the chi-
square test (or Fishers’ exact test when appropriate). Fur-
thermore, the quality of sex life and the additional
questions at the various follow-up moments were compared
to baseline, yielding two different options: ‘‘worse,’’ ‘‘the
same,’’ or ‘‘better’’ compared to baseline. Differences
between the groups were compared with the chi-square test
(or Fishers’ exact test when appropriate).
Logistic regression analysis was performed to investi-
gate variables associated with a worse sexual life quality at
24 months after treatment compared to baseline versus
unchanged or improved quality of sexual life. First, uni-
variate analysis was performed with the following baseline
characteristics: intended treatment, age, BMI, parity, eth-
nicity, having a partner, employment status, smoking
status, number of ﬁbroids, uterine volume measured by
ultrasound, dominant ﬁbroid volume measured by ultra-
sound, existence of any comorbid disease, and mental
health status (MCS-MOS-SF36) at baseline. Second, co-
variates with p values <0.1 in the univariate analysis were
selected for multivariate analysis.
All analyses were two-tailed and carried out based on
the intention-to-treat principle. A p value <0.05 (two-
tailed) was considered statistically signiﬁcant.
Results
Patients were enrolled between March 2002 and February
2004. Of 349 eligible patients, 177 were randomized: 89
were allocated hysterectomy and 88 were allocated UAE.
In the hysterectomy group 14 patients refused the allocated
treatment, compared to 7 patients in the UAE group, and
these patients withdrew from participation. In 4 UAE
patients embolization failed bilaterally. These patients
subsequently had a hysterectomy but were analyzed in the
UAE group according to the intention-to-treat principle
(Fig. 1)[ 15]. The baseline characteristics of all randomized
patients are reported in Table 2. No differences between
the groups are apparent, as expected considering the ran-
domized design.
The proportion of questionnaires available for analysis
ranged from 96.0% (baseline) to 98.7% (6 weeks, 24
months). Before treatment 54 of 81 (67%) and 46 of 75
(61%) of the participating patients were sexually active in
the UAE and hysterectomy groups, respectively (Fig. 2A).
Six weeks after treatment, sexual activity had decreased in
both groups, with signiﬁcantly more patients showing
sexual activity in the UAE group compared to hysterec-
tomy (53% versus 29%; p = 0.004). Hereafter sexual
activity was restored in both groups, with no signiﬁcant
differences between the groups at 24 months (p = 0.07).
Patients who were not sexually active before treatment
gradually resumed sexual activity after both UAE and
hysterectomy (Fig. 2B). After 24 months 31% (hysterec-
tomy) and 52% (UAE) were sexually active (p = 0.118).
No signiﬁcant differences were observed between the
groups.
Among those patients who were sexually active before
treatment, there was a major drop in activity at 6 weeks
after treatment, which was partially restored. After 2 years,
86% (UAE) and 90% (hysterectomy) of these patients had
resumed their sexual activities (Fig. 2C). Only at 6 weeks
had signiﬁcantly more UAE patients resumed sexual
activity (p = 0.01).
Figure 3 shows the course of the SAQ dimensions
pleasure, discomfort, and habit and the BIS scores over
time. There were no differences between the groups at
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Fig. 1 Flowchart
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123baseline (pleasure, p = 0.76; discomfort, p = 0.44; habit, p
= 0.77; body image,: p = 0.60). Repeated measurements
revealed no differences between the groups for the SAQ
dimensions pleasure (p = 0.343), discomfort (p = 0.246),
and habit (p = 0.453) or for body image scores (p = 0.359).
Table 3 shows the changes in dimension scores per treat-
ment group for patients who were sexually active at
baseline. Positive numbers for pleasure and habit and
negative numbers for discomfort and body image are
indicative for improvement compared to baseline. No sig-
niﬁcant differences were found between the two treatment
groups at all time points, except for body image at 6
months after treatment: body image had improved signiﬁ-
cantly more in UAE patients than in hysterectomy patients
(UAE, –1.34, versus hysterectomy, no change; difference,
–1.34; 95% CI, –2.50 to –0.18; p = 0.02). Within the
groups, however, a signiﬁcant improvement of various
dimension scores was noted (indicated in boldface): at 24
months UAE patients reported signiﬁcantly less discom-
fort, a higher frequency of intercourse, and a better body
image compared to baseline (p = 0.022, p = 0.022, and p =
0.009 respectively). At 24 months hysterectomy patients
improved on all dimensions compared to baseline, but
differences were not statistically signiﬁcant.
Table 4 reports the patients’ experienced quality of their
sexual life at 6 weeks and 12 and 24 months. No differ-
ences between groups were observed. Table 5 presents the
proportion of patients who judged the quality of sexual life
as better, comparable to, or worse compared to baseline
based on the question: ‘‘How is the quality of your current
sexual life?’’ A minority of patients reported worsened
sexual life quality compared to baseline at all time points.
At 24 months the proportion of patients reporting a worse
sexual life compared to baseline was slightly higher in the
Table 2 Baseline
characteristics
a Some values are missing
b Any of the following:
hypertension, diabetes, astma,
clotting disease, system disease,
or other
UAE (N = 88) Hysterectomy (N = 89)
Age (yr), mean (SD) 44.6 (4.8) 45.4 (4.2)
Body mass index (weight [kg]/length [m]
2), mean (SD) 26.7 (5.6) 25.4 (4.0)
Parity (n)
0 30 (34.1%) 20 (22.5%)
1 58 (65.9%) 69 (77.5%)
Ethnicity (n)
Black 24 (27.3%) 20 (22.5%)
White 54 (61.4%) 57 (64.0%)
Other 10 (11.4%) 12 (13.5%)
Marital status
a (n)
Single 16 (18.2%) 13 (14.8%)
Married 55 (62.5%) 54 (61.4%)
Living apart together 5 (5.7%) 4 (4.5%)
Divorced 12 (13.6%) 15 (17.0%)
Widow 0 (0%) 2 (2.3%)
Partner relationship
a (n)
No partner 13 (15.3%) 19 (22.4%)
Partner 72 (84.7%) 66 (77.6%)
Employment status
a (n)
Employed 68 (77.3%) 69 (78.4%)
Unemployed 20 (22.7%) 19 (21.6%)
Smoking status (n)
Current smoker 21 (23.9%) 23 (25.8%)
Former smoker 11 (12.5%) 14 (15.7%)
Nonsmoker 56 (63.6%) 52 (58.4%)
Comorbid disease
b
Any comorbid disease 24 (27.3%) 22 (24.7%)
Number of ﬁbroids, median (range) 2 (1–20) 2 (1–9)
Uterine volume (cm
3), median (range) 321 (31–3005) 313 (58–3617)
Fibroid volume (dominant ﬁbroid; cm
3), median (range) 59 (1–673) 87 (4–1641)
Mental Component Summary (SF-36), mean (SD) 40.9 (10.7) 41.5 (11.0)
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was not statistically signiﬁcant (29.3% versus 23.5%; p =
0.43).
Univariate logistic regression analysis revealed BMI,
number of ﬁbroids, and presence of comorbid disease to be
associated with a worsened quality of sexual life at 24
months compared to baseline (p < 0.1). Allocated treatment
and mental health at baseline were not associated with
worse outcome.
BMI was not signiﬁcant in the multivariate analysis
(p = 0.163). The other two parameters remained signif-
icantly associated with worse outcome: a higher number
of ﬁbroids (OR, 0.69; 95% CI, 0.51–0.94; p = 0.018)
predicted a decreased risk of a worsening sexual life
at 24 months compared to baseline, while the pres-
ence of comorbid disease (OR, 3.20; 95% CI, 1.38–7.41;
p = 0.007) was associated with an increased risk of a
worse sexual life quality at 24 months after treatment
compared to baseline.
Discussion
In our trial no differences, on average, in sexual function at
24 months were observed between UAE and hysterectomy.
After both treatments the dimensions ‘‘pleasure’’ and
‘‘habit’’ improved, while the dimension ‘‘discomfort’’
decreased at 24 months compared to baseline, although
only the UAE group showed signiﬁcant improvement in
discomfort and frequency of intercourse.
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123Sexuality and body image after UAE have never been
evaluated in a randomized controlled trial before. However,
somenonrandomizedserieshaveaddressedthissubject.The
improvement of sexual functioning after UAE was in
accordance with the limitednumberofearlierstudies on this
subject [26–28], which reported a signiﬁcant improvement
in sexual functioning as well. Sexual functioning after hys-
terectomy has received much attention in the literature.
Improvement in sexual functioning after hysterectomy
might indirectly be associated with the consequences of
surgery, such as less worry about unwanted pregnancy,
absence of vaginal bleeding, and more time for sexual
activities by the cessation of monthly periods [29]. Most
reports on sexual functioning after hysterectomy found sig-
niﬁcantbeneﬁtsinvariousaspectsofsexualfunctioning[25,
30–35]. In contrast, the improvement in sexual functioning
within our hysterectomy group at 24 months of follow-up
was not statistically signiﬁcant in our trial. This might be
explained by insufﬁcient power, which is partly due to the
relatively small sample size for the SAQ scores in our pop-
ulation:changescoreswereonlyavailablefromwomenwho
were sexually active at baseline and at follow-up. Further-
more, the studies on sexuality after hysterectomy used
varying follow-up intervals, ranging from 6 months to 2
years. In our series, hysterectomy patients experienced sig-
niﬁcantly improved pleasure and habit scores at 12 months
offollow-up.Theseresultsmightindicatethatimprovement
in sexual functioning after hysterectomy could be tempo-
rary. On the other hand, a review article recently suggested
that there is no scientiﬁc proof for either improvement or
deterioration of sexual functioning after hysterectomy,
unless hysterectomy was performed based on a sound clin-
icalindication[29].Inourpatientgroup,however,therewas
no doubt about the indication: complaints were serious and
lengthy enough to warrant a hysterectomy.
Although, on average, SAQ scores for the group as a
whole improved, there was a small group of women who
reported a deterioration in self-reported quality of sexual
life, consistent with other reports [30–32, 34, 36]. For
obvious reasons, the prospects of deterioration of sexual
life might be of greater concern to patients than the
improvement after treatment. Regression analysis of
worsened sexual life revealed that women with a low
number of ﬁbroids (possibly representing a group of
women with less severe complaints) and women with other
concomitant chronic diseases might not beneﬁt from
ﬁbroid treatment in terms of sexual life improvement.
The improved body image after UAE in our series is in
accordance with another study that reported higher self-
consciousness after UAE [26]. After hysterectomy a period
of temporary worsened body image following the opera-
tion has been described previously [25, 36, 37]. This was
not conﬁrmed by our results, but in accordance with these
studies, a normal or even improved body image was found
1 year after hysterectomy.
There are several limitations of our study that need to be
addressed. First, the values of the SAQ dimensions were
based on all sexual active women at the various points in
time. Reported values may reﬂect an ever-changing group
of sexually active women. At any stage, some women may
cease while others may initiate sexual activity. Of all non-
sexually active women before treatment, 50% became
active after treatment. When comparing pre- and post-
treatment scores, these women cannot be included, since
their baseline scores were missing.
Second, the signiﬁcant difference between resumption
of sexual activity between the groups at 6 weeks is prob-
ably explained by differences in counseling between both
treatments as mentioned earlier: hysterectomy patients in
our trial were told not to have sex until the ﬁrst outpatient
Table 3 Mean differences in pleasure, discomfort, habit, and body
image compared to baseline, by treatment strategy, over time
UAE Hysterectomy p value
SAQ: pleasure (0–18)
a
6 wk 0.29 0.50 0.47
6m o 1.63 1.23 0.61
12 mo 0.95 1.49 0.50
18 mo 1.86 0.68 0.13
24 mo 0.89 1.18 0.74
SAQ: discomfort (0–6)
b
6w k 0.25 0.21 0.96
6m o 0.58 0.32 0.41
12 mo 0.47 0.47 0.98
18 mo 0.51 0.29 0.51
24 mo 0.43 0.49 0.88
SAQ: habit (0–3)
a
6w k 0.03 0.00 0.92
6m o 0.48 0.28 0.30
12 mo 0.18 0.42 0.24
18 mo 0.27 0.19 0.70
24 mo 0.28 0.22 0.74
BIS (0–30)
b
6w k 1.27 0.28 0.10
6m o 1.34 0.00 0.02
12 mo 0.24 0.08 0.64
18 mo 1.24 –0.28 0.15
24 mo 1.06 –0.50 0.36
Note. SAQ, Sexual Activity Questionnaire; BIS, Body Image Scale.
Boldface numbers indicate a signiﬁcant difference from baseline
within group (p < 0.05)
a A higher score represents more favorable sexual functioning
(pleasure, habit)
b A lower score represents more favorable sexual functioning (dis-
comfort) or body image
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123visit at 6 weeks, while UAE patients were advised to
refrain from intercourse for at least 2 weeks and thereafter,
depending on their complaints.
Third, we allowed all kinds of hysterectomies, thereby
possibly biasing the results in the hysterectomy group.
However, various reports found no long-term differences in
sexual functioning after various surgical routes of hyster-
ectomy [25, 32, 35].
Finally, as described above, three questions on the BIS
were omitted because of wrongly posed questions, thereby
creating asymmetry in the treatment arms. Since the
remaining questions in both groups were identical, the
comparison between the groups is still valid but reduces
the comparability with other series.
In conclusion, at 24 months no differences in sexuality
and body image were observed between the UAE and the
hysterectomy groups. After both UAE and hysterectomy,
on average, sexual functioning and body image scores
improved, but signiﬁcantly so only after UAE.
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